Nanbiosis https://validator.w3.org/feed/docs/rss2.html NANBIOSIS showcases colloidal characterization expertise at the 54 CED Annual Meeting U28-S016. Confocal Microscopy U28. NanoImaging Unit Zeiss LSM 980 NLO Multiphoton Confocal Microscope Spanish biotech calls for stronger strategic autonomy at the Ministry of Science Lucía Enríquez at Kyoto University: Advancing Cystic Fibrosis Research Through iPS Technology NANBIOSIS strengthens science–industry collaboration at Science for Industry (S4i) 2026 round table NANBIOSIS advances targeted nanomedicine for Acute Myeloid Leukemia on World Cancer Day U26-E07. MRS*DRYMAG3017/MRS*PET CLIP-ON MR SOLUTIONS U26. NMR: Biomedical Applications II U26-E01. DRX-600 Bruker NM R equipment (14 Teslas) U26-E02. -NMR microscopy system for imaging Bruker 14T U26-S06. Biomedical and metabolomic imaging U26-E05 Bruker Avance III 400 WB spectrometer, with ultrashielded widemouth magnet (89 mm), 400 MHz (9.4 T), with two RF channels and high power amplifiers for solid-state experiments. U26-E03. Bruker Neo500 spectrometer (11.7 T), and with three RF channels NANBIOSIS Unit 6 inspires future scientists with school visit to ICMAB-CSIC NANBIOSIS Revalidated as a Unique Scientific and Technical Infrastructure (ICTS) in Spain Competitive calls 2026 1st Competitive call 2026 How a tumor metabolite changes Glioma behavior and improves treatment response CALL NANBIOSIS researchers contribute to the 2nd CSIC Rare Diseases Network Meeting in Madrid MSCA COFUND Fellows Gather in Madrid for National Networking Event Organised by FECYT and CIBER U16. Surface Characterisation and Bacterial Colonization Unit Development and characterization of aerosolized formulations for pulmonary administration Home Lluis Montoliu: how to communicate research from the lab to society NANBIOSIS and IBIMA: new bioimaging techniques in cutting-edge research Ready your proposals: Our Open Call starts on january 2025 NANBIOSIS receives the support of the Spanish Research Agency (Ministry of Science and Innovation) financing the NANBIO-ACCESS project, in the 2022 call for Excellence Research Networks. 2nd Open call 2024 for preferential access to the ICTS NANBIOSIS 1st Open call 2024 for preferential access to the ICTS NANBIOSIS Resolution of the 1st competitive call of 2024 for access to NANBIOSIS Ready your proposals: Open Call starts on january NANBIOSIS Launches Its Official Newsletter Resolution of the 1st competitive call of 2026 for access to NANBIOSIS Ready your proposals: Our Open Call starts on june Open Position: Science Communicator for NANBIOSIS ICTS in Valencia Resolution of the 2nd competitive call of 2025 for access to NANBIOSIS Resolution of the 2nd competitive call of 2024 for access to NANBIOSIS New animal study reveals overlooked fecal metabolites linked to early liver disease under high-fat diet U26-S04. In vivo NMR of small animals (zebrafish,Drosophila) NANBIOSIS Unit 2 (CAbS) at the III SENTIATECH Meeting on Science, Technology & Health Risk Monitoring Preclinical Histology Workflow within NANBIOSIS U2. Custom Antibody Service Unit (CAbS) U1. Protein Production Platform Unit (PPP) U6. Soft Materials Service: Preparation and characterization of nano- and microstructured molecular soft materials U19. Animal Modelling Unit U7. MicroFab & Microscopy Unit U20. Functional Validation & Preclinical Research (FVPR)